Texas Capital Bancshares Inc/Tx (TCBIO) EBT (2010 - 2026)

Texas Capital Bancshares (TCBIO) has reported EBT for 17 consecutive years, with $112.0 million the latest figure, recorded in Q2 2026.

• Quarterly EBT rose 9.6% year-over-year to $112.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $476.5 million (up 170.46% YoY) and the FY2025 annual result came in at $432.7 million, up 304.17% from the prior year.
• EBT rose to $112.0 million in Q2 2026 per TCBIO's latest filing, from $94.4 million in the prior quarter.
• Over the last five years, EBT for TCBIO reached as high as $278.2 million in Q4 2022 and fell as low as -$80.0 million in Q3 2024.
• A 5-year average of $79.1 million and a median of $70.8 million in 2023 frame the typical range for EBT.
• Annual changes were most pronounced in 2024 — EBT plunged 198.69% — and 2025, when it soared 272.24%.
• Year by year, EBT stood at $278.2 million in 2022, then plunged by 90.85% to $25.5 million in 2023, then jumped by 267.26% to $93.5 million in 2024, then surged by 41.45% to $132.3 million in 2025, then declined by 15.33% to $112.0 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $112.0 million, $94.4 million, and $132.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.